Incorporating a lipophilic linker proximal to the albumin binder subtly elevates the tumor-to-kidney ratios of the radioconjugates, while the employment of a hydrophilic linker attenuates albumin-binding capabilities, leading to suboptimal tumor-to-kidney ratios, as demonstrated with folate radioconjugates. This evidence concerns the gene ALB and neoplasm.